This track will explore the intricate relationship between the immune system and neurological function, emphasizing recent advancements in neuroimmunology. Discussions will focus on how immune-mediated mechanisms contribute to neurological disorders and potential therapeutic targets.

This session will delve into the pathophysiology and clinical manifestations of autoimmune disorders affecting the nervous system. Researchers will present findings on diagnostic challenges and innovative treatment approaches.

Focusing on multiple sclerosis, this track will cover the latest research on its etiology, progression, and management strategies. Participants will discuss novel therapeutic interventions and the role of neuroinflammation in disease progression.

This session will investigate the cellular and molecular mechanisms underlying neuroinflammation in various neurological disorders. Emphasis will be placed on the implications of neuroinflammatory processes for disease outcomes and therapeutic interventions.

This track will highlight the spectrum of immune-mediated neurological disorders beyond multiple sclerosis, including neuromyelitis optica and autoimmune encephalitis. Presentations will focus on diagnostic criteria, treatment modalities, and patient management.

This session will address the role of myelin in neurological health and the impact of myelin disorders on brain function. Researchers will discuss current therapeutic strategies aimed at myelin repair and regeneration.

Focusing on diagnostic techniques in immunology, this track will present innovative approaches for identifying autoimmune neurological disorders. Participants will explore the role of biomarkers and imaging technologies in enhancing diagnostic accuracy.

This session will examine the neurobiological underpinnings of immune responses in the central nervous system. Discussions will center on how these interactions influence neurological health and disease.

This track will focus on the clinical aspects of neurology, addressing challenges in diagnosing and managing autoimmune neurological disorders. Presenters will share innovative practices and research findings that aim to improve patient outcomes.

This session will provide an overview of current trends in neuroimmune research, highlighting interdisciplinary approaches and collaborations. Participants will discuss emerging findings and their implications for understanding and treating neurological disorders.

Focusing on the role of immune therapy in neurological disorders, this track will explore various therapeutic strategies, including monoclonal antibodies and immunomodulatory agents. Presentations will highlight clinical trial results and future directions in immune-based treatments.